Closed system solutions for cell and gene therapy manufacturing
Sponsor
Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast ye tinteractive format.
Cell therapies offer a promising approach to treat severe and rare diseases. However, sustained manufacturing of cell therapy products is at risk due to the high costs associated with manufacturing variability and safety assessments. One significant risk in the manufacturing process is contamination of product, which can contribute to millions of dollars in added cost. In this webinar, we will address how integrating closed system approaches during process development or manufacturing can mitigate contamination risk and associated costs.
This webinar will introduce viewers to Corning’s closed system solutions, with attention to the following topics:
- Assembly and customization of closed systems
- Closed system process considerations and flexibility in design
- Scaling up and out using closed systems
Attend this webinar to learn more about:
- Benefits of closed systems
- Assessing risk of contamination
- Key considerations for closed system design
SPEAKERS
You might also like
Can primary packaging selection help mitigate particulate risks in cell and gene therapy manufacturing?
Trends in innovation for downstream process intensification, product yield, single-use closed systems, and gentle ATMP bioprocessing: a KOL panel discussing 2024 insights in gene therapy manufacturing
Creating a closed-process, semi-automated workflow for human MSC expansion, harvest, and final fill
Improving AAV productivity: a technical deep-dive into next-generation solutions for cell and gene therapy applications
